Cipher Pharmaceuticals Inc. logo

Cipher Pharmaceuticals Inc. (CPHRF)

Market Closed
8 Dec, 20:00
OTC GREY OTC GREY
$
10. 70
+0.12
+1.13%
$
271.99M Market Cap
- P/E Ratio
0% Div Yield
3,300 Volume
- Eps
$ 10.58
Previous Close
Day Range
10.59 10.79
Year Range
6.63 12.5
Want to track CPHRF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Bryan Jacobs - President Craig J. Mull - Interim CEO & Chairman of the Board Ryan Mailling - Chief Financial Officer Conference Call Participants Andre Uddin - Research Capital Corporation, Research Division Douglas W.

Seekingalpha | 4 months ago
Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Ryan Mailling - Chief Financial Officer Conference Call Participants Andre Uddin - Research Capital Justin Keywood - Stifel Doug Loe - Leede Financials Operator Good morning, ladies and gentlemen. Thank you for standing by.

Seekingalpha | 7 months ago
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript

Cipher Pharmaceuticals Inc. (OTCQX:CPHRF) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Craig Mull - Interim CEO Ryan Mailling – CFO Bryan Jacobs - President of U.S. Operations Conference Call Participants Andre Uddin - Research Capital Justin Keywood – Stifel Operator Good morning, ladies and gentlemen. Thank you for standing by.

Seekingalpha | 8 months ago